Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies

Published:2012-08 Issue:7 Volume:23 Page:724-730
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

von Gruenigen Vivian E.,Frasure Heidi E.,Smith Deborah A.,Fusco Nancy L.,Eaton Susan M.,DeBernardo Robert L.,Heugel Anne M.,Waggoner Steven E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference24 articles.

1. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.;Gordon;J Clin Oncol,2001

2. Weekly topotecan for recurrent endometrial cancer: a case series and review of the literature.;Traina;Gynecol Oncol,2001

3. Review role of topotecan in gynaecologicial cancer: current indications and perspectives.;Lorusso;Crit Rev Oncol Hematol,2010

4. Adherence to therapy with oral antineoplastic agents.;Partridge;J Natl Cancer Inst,2002

5. Patient preferences for oral versus intravenous palliative chemotherapy.;Liu;J Clin Oncol,1997

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herbal Medicines as Adjuvants for the Treatment of Chemotherapy-Induced Diarrhea;Current Drug Metabolism;2023-06

2. Tdp1 protects from topoisomerase 1–mediated chromosomal breaks in adult zebrafish but is dispensable during larval development;Science Advances;2021-01-29

3. Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours;British Journal of Cancer;2015-08-20

4. Toxicogenomics profiling of bone marrow from rats treated with topotecan in combination with oxaliplatin: a mechanistic strategy to inform combination toxicity;Frontiers in Genetics;2015-02-12

5. Le rôle des cohortes d’expansion dans les essais de phase I en cancérologie : des recommandations du HUB phase I;Bulletin du Cancer;2015-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3